ArticleDigestive diseases and sciences2026
Reflecting on Quality-of-Care Delivery in Inflammatory Bowel Disease Pregnancy: The (Pause and Reflect) PAUSA Study.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeInflammatory bowel diseases (IBD) have been associated with adverse outcomes during pregnancy, with guidelines developed to inform clinical practice. This study reviewed adherence to guidelines amongst different healthcare providers caring for individuals with IBD during pregnancy.
methodsA retrospective multi-centre study of individuals with IBD who received antenatal IBD care at three Australian tertiary units from 2023 to 2025 was undertaken. Clinical documentation for each pregnancy was reviewed against nine process indicators derived from the European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy and Lactation [1]. The primary outcome was the proportion of process indicators followed by speciality per pregnancy.
resultsForty-three pregnancies amongst 43 individuals were included; 19 (44.2%) had ulcerative colitis. Twenty-six pregnancies (60.5%) were to individuals on biologic therapy for IBD at time of conception. Gastroenterologists met a median 6/9 (67%) process indicators, Obstetrics/Maternofetal Medicine specialists met a median 3/9 (33%) process indicators, and Other Specialists (combined) met a median 1/9 (11%) process indicators per pregnancy. The number of clinic visits and proportion of process indicators followed correlated positively. Adherence to preconception counselling, mental health assessment, and venous thromboembolism risk assessment was particularly poor, completed by Gastroenterology in 39.5, 34.9 and 4.7% of cases, respectively, compared to 4.7, 25.6 and 46.5% of cases by obstetric care providers.
conclusionsUptake of guideline recommendations for antenatal IBD management was variable between different speciality providers in this study of patients with moderate-to-severe IBD. Uptake of recommendations may be improved by increasing access to multidisciplinary care and frequent clinical contact. Whether improvements in adherence with process indicators translates to improved clinical outcomes warrants further evaluation in IBD pregnancy.
Indexed as
Identifiers
42844504What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.